This Unity Software Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Tuesday

1stdibs.com, Inc. -0.34% Post
Iovance Biotherapeutics Inc +4.95% Post
Unity Software, Inc. +8.18% Post
Block, Inc. Class A +2.75% Post

1stdibs.com, Inc.

DIBS

5.80

5.80

-0.34%

0.00% Post

Iovance Biotherapeutics Inc

IOVA

3.82

3.83

+4.95%

+0.26% Post

Unity Software, Inc.

U

25.26

25.40

+8.18%

+0.55% Post

Block, Inc. Class A

XYZ

67.97

67.67

+2.75%

-0.44% Post

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • B of A Securities analyst Omar Dessouky upgraded Unity Software Inc. (NYSE:U) from Underperform to Neutral and raised the price target from $18 to $19. Unity Software shares closed at $18.87 on Monday. See how other analysts view this stock.
  • Northland Capital Markets analyst Robert Brooks upgraded 1Stdibs.Com Inc (NASDAQ:DIBS) from Market Perform to Outperform and maintained the price target of $7. 1stdibs.com shares closed at $5.33 on Monday. See how other analysts view this stock.
  • HSBC analyst Saul Martinez upgraded Block Inc (NYSE:XYZ) from Hold to Buy and raised the price target from $70 to $77. Block shares closed at $64.45 on Monday. See how other analysts view this stock.
  • Citizens analyst Reni J. Benjamin upgraded Iovance Biotherapeutics Inc (NASDAQ:IOVA) from Market Perform to Market Outperform and announced a $5 price target. Iovance Biotherapeutics shares closed at $3.79 on Monday. See how other analysts view this stock.

Considering buying U stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.